Global Amoxicillin Sodium Market

Global Amoxicillin Sodium Market, By Route of Administration (Capsule, Tablet, Injection); By Application (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy); By Region (North America, Europe, Asia Pacific, and Rest of the World); Trend Analysis, Competitive Market Share & Forecast, 2021-2027.

  • Published Date: January 2021
  • Report ID: BWC20281
  • Available Format: PDF
  • Page: 178

Report Overview

Global Amoxicillin sodium Market size- Industry Trends & Forecast Report 2027.

 

The global amoxicillin sodium market is estimated to reach USD 679.1 million by 2020 and is further projected to reach USD 905.2 million by 2027, growing at a CAGR of 4.9% during 2021-2027 (forecast period). The amoxicillin sodium market is likely to grow in the forecast timeframe due to the growing bacterial infections. Amoxicillin sodium is a common antibiotic used to treat several bacterial infections. These infections include middle ear infections, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection. Amoxicillin is a common bactericidal drug i.e.,it does not directly kill the bacteria but instead stops the bacteria from multiplying.


Source: BlueWeave Consulting


Global Amoxicillin sodium Market Overview:

Amoxicillin Sodium is defined as the sodium salt form of a broad-spectrum. It is categorized as a semisynthetic aminopenicillin antibiotic with bactericidal activity. Amoxicillin binds and inactivates penicillin-binding proteins that are located on the inner membrane of the bacterial cell wall. This medication is a penicillin-type antibiotic. It functions by stopping the growth of bacteria. This antibiotic doesn't work for viral infections (such as the common cold, flu). Amoxicillin Sodium is also used with other medications to treat stomach/intestinal ulcers that are caused by the bacteria H. pylori.

 


 

Amoxicillin sodium Market Forecast and Trends

 

Growth Drivers 

 

Growing Bacterial Infections

The growing bacterial infections are driving the demand for amoxicillin sodium in the market. For instance, In the U.S., antibiotic-resistant bacteria cause at least 2 million infections in the last years and 23,000 deaths a year resulting in a $55–70 billion per year economic impact. These antibiotics are critical to the success of surgical procedures including orthopedic prosthetic surgeries. The symptoms associated with bacterial infection may persist longer than the expected 10-14 days a virus tends to last. Fever is higher than one might typically expect from a virus. Fever gets worse a few days into the illness rather than improving.


 

Benefits of using amoxicillin sodium

Amoxicillin is a common antibiotic and belongs to the class of penicillin. it is effective against various bacteria such as Streptococcus, Staphylococcus, H. influenzae, N. gonorrhea, E. coli, Pneumococci, and many others. The food and drug administration approved Amoxicillin in December 1974. Amoxicillin is a bactericidal drug i.e., it does not directly kill the bacteria but instead stops the bacteria from multiplying and its growth doesn't replicate. Amoxicillin acts by inhibiting bacterial cell wall synthesis. The cell wall is necessary to protect the bacteria from the external environment and keeps the bacteria safe. Hence, the bacteria can't survive without a cell wall.

 

Restraints 

 

Side effects associated with amoxicillin Sodium

There are various side effects associated with the use of amoxicillin sodium and this factor can hamper the growth of the market. The electrolyte disturbances such as hypokalaemia (due to administration of large amounts of sodium). Hyperkinesia, dizziness, and convulsions Signs of central nervous system toxicity; generally associated with large intravenous doses of amoxicillin and even impaired renal function are the most common side effects of amoxicillin sodium. It upsets the empty stomach, thus necessary to take it with food. Amoxicillin can also alter the normal and healthy bacteria in the colon and lead to overgrowth of Clostridium difficile bacteria. This leads to inflammation of the colon known as pseudomembranous colitis.

 

Impact of COVID-19 in industry

 

The global economy and humanity have been pushed into a crisis due to the COVID-19 pandemic. Due to the high infection rate and adverse impact on public health systems, various governments have enforced nationwide lockdowns significantly impacting manufacturing supply chains, trade, and related services. Players are currently considering digital solutions that would enable them to serve the community and provide new opportunities to do business. The production, manufacturing, supply chain, and other operations, have slowed down globally aimed to limit the spread of the coronavirus,

The global impact of the coronavirus disease 2019 (COVID-19) is likely only beginning and would significantly affect the Amoxicillin sodium market in 2020. The outbreak of COVID-19 has brought with it travel bans and quarantines; massive slowing of the supply chain; uncertainty in the stock market; falling business confidence, and growing panic among the population. Despite the growing uncertainty and panic, technology suppliers must continue to focus on their long-term investments, maintain engagement with partners and prospects, and look to specific markets for stability.



Amoxicillin sodium Market: By Route of Administration

 

Based on the route of administration, the Amoxicillin sodium market is segmented into the capsule, tablet, and Injection. The Injection segment is likely to dominate in the market followed by capsules. Amoxicillin may be removed from the circulation by hemodialysis. Though, the standard recommended for amoxicillin sodium route of administration is by intravenous injection or intravenous infusion. Otherwise, Intramuscular administration should only be considered when the intravenous route is not possible or less appropriate for the patient. The drug got absorbed in the duodenum and jejunum along with no significant differences in absorption when administered as a bolus or 4-hour infusion.


Source: BlueWeave Consulting


Amoxicillin sodium Market: Regional Insight

North America region is likely to dominate in the Amoxicillin sodium market, followed by the Asia Pacific, and others. Developing countries like the US and Canada have major opportunities for industrial production, retail sales, and fixed-asset investment for Amoxicillin sodium. Several other economies such as Indonesia, the Philippines, and Singapore in the Asia Pacific region are also forecast to grow at modest rates. The company's productivity is directly proportional to the productivity of workers. Hence, businesses in these regions are commonly embracing different instruments to help workers increase their productivity.



Source: BlueWeave Consulting


Recent Development

 

·         In 2019, the FDA approved a new antibiotic that can treat community-acquired bacterial pneumonia. The U.S. Food and Drug Administration today approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.

 

·         The recent studies discovered that taking probiotics during and after a course of antibiotics can help reduce the risk of diarrhea and restore the gut microbiota to a healthy state. 

 

Competitive landscape

The Amoxicillin sodium market is fragmented owing to the presence of several companies that provides varied Amoxicillin sodium products. However, the companies that hold the majority share of the Amoxicillin sodium market are GlaxoSmithKline, Pfizer PLC, Bayer AG, Novartis AG, and Abbott Inc., Toku-e, Abcam, Alfa Aesar, Tul, Hayao, Cspc, Eli Lilly And Company, Merck, CSPC, and others, prominent players.

In the Amoxicillin sodium market, prominent market participants compete based on price and product quality. Small and medium-sized market players are expected to show considerable improvements in the foreseeable future, given the moderate level of capital expenditure needed to set up a business. The large-sized companies, however, are likely to aim for global expansion, in a bid to gain a more considerable brand reputation.

 

 

Scope of the Report

Attribute

Details

Years Considered

Historical data – 2016-2019

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Russia, Brazil, Japan, South Korea, China, UAE, South Africa, UAE, Turkey, India, Rest of APAC, Mexico, Argentina, Rest of Latin America, Saudi Arabia, Rest of MEA, Rest of Europe, GCC

Product/Service Segmentation

By Route of Administration, By application, and By Region

Key Players

Glaxosmithkline, Pfizer PLC, Bayer AG, Novartis AG, and Abbott Inc., Toku-e, Abcam, Alfa Aesar, Tul, Hayao,Cspc, Eli Lilly And Company,Merck, CSPC, and othersprominent players.

 

 



Scope of the Report


By Route of Administration

Ø  Capsule

Ø  Tablet

Ø  Injection

By Application

Ø  Hospital Pharmacy

Ø  Retail Pharmacy

Ø  Online Pharmacy

By Region

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Middle East and Africa

Ø  Latin America